Nutrigenomics testing is revolutionizing preventive healthcare by enabling individuals to understand how their genes interact with nutrients and dietary patterns. Through advanced genetic analysis, nutrigenomics testing helps healthcare professionals develop personalized nutrition strategies designed to optimize health outcomes and reduce disease risks. The growing adoption of genetic testing technologies is significantly accelerating the growth of the global Nutrigenomics Market.

According to Polaris Market Research, the global Nutrigenomics Market was valued at USD 482.65 million in 2024 and is expected to reach USD 2,334.89 million by 2034, growing at a CAGR of 17.1% during the forecast period from 2025 to 2034. Rising demand for personalized nutrition and increasing awareness regarding preventive healthcare are major factors driving market expansion.

Nutrigenomics testing analyzes specific genetic markers that influence how individuals metabolize nutrients, respond to dietary components, and develop disease risks. Based on these insights, healthcare providers can recommend customized dietary strategies tailored to each person’s genetic profile.

One of the major drivers supporting the growth of nutrigenomics testing is the increasing prevalence of chronic diseases worldwide. Conditions such as obesity, cardiovascular diseases, diabetes, and cancer are closely associated with dietary habits and genetic predispositions. Nutrigenomics testing enables more targeted nutritional interventions aimed at preventing or managing these chronic conditions effectively.

The saliva collection segment currently dominates the Nutrigenomics Market by technique because saliva-based testing offers a convenient, non-invasive, and user-friendly method for DNA collection. Saliva tests are widely used in direct-to-consumer genetic testing services and clinical nutrition programs due to their ease of use and accessibility.

The reagents and kits segment currently holds the largest product share because these products are essential for DNA extraction, genetic sequencing, and laboratory analysis. However, the services segment is expected to witness the fastest growth during the forecast period due to rising demand for personalized healthcare consultations and nutrition planning services.

Read More @ https://www.polarismarketresearch.com/industry-analysis/nutrigenomics-market

Hospitals and clinics remain the largest end-use segment in the Nutrigenomics Market as healthcare providers increasingly incorporate genetic testing into preventive healthcare programs and chronic disease management strategies. Growing consumer interest in wellness optimization is also driving adoption across wellness centers and direct-to-consumer healthcare companies.

North America currently accounts for the largest market share because of strong healthcare infrastructure, widespread genetic testing adoption, and increasing consumer awareness regarding personalized wellness. Asia Pacific is expected to witness substantial growth due to expanding healthcare access, rising chronic disease prevalence, and increasing investments in biotechnology and precision medicine.

Several leading companies including 23andMe, DNAfit, Mapmygenome, and The Gene Box continue investing in advanced nutrigenomics testing technologies to improve personalized healthcare accessibility globally.

As precision medicine and preventive healthcare continue evolving, nutrigenomics testing is expected to play an increasingly important role in helping individuals make data-driven dietary decisions and improve long-term health outcomes worldwide.

More Trending Latest Reports By Polaris Market Research:

AI-optimization for quantum computing market

Active Pharmaceutical Ingredient Market

Electric Kick Scooters Market

EMEA Point-Of-Care Diagnostics Market

Carboprost Tromethamine Market

Antibiotics Market

Muscle Relaxant Drugs Market

Welding Materials Market

Furfural Market